Analysis

3 Questions As Moderna Wages COVID Patent Attack On Pfizer

By Dani Kass (August 26, 2022, 10:30 PM EDT) -- Moderna's suits accusing Pfizer of infringing patents related to mRNA vaccine technology on Friday set the stage for courts to review the role of no-sue pledges such as the one Moderna made in October 2020 as well as whether the suing company should have patents in the first place....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!